NusaTrip Announces Receipt of Delisting Notice from Nasdaq
1 min read
The story
NusaTrip announced that it received a Nasdaq Staff Delisting Determination on August 3, 2026. The company said it will not appeal the decision and plans to seek over-the-counter trading instead.
The immediate consequence is the loss of NusaTrip’s Nasdaq listing, shifting the company toward a less liquid and less visible trading venue. NTRP reported revenue of $3.7M, up 641.0% YoY, but its diluted EPS was $-1.82, so the headline growth does not remove the listing and profitability concerns.
The enrichment also shows 17.6% gross margins and 437.3% net margins, a combination that is difficult to interpret without further context and does not offset the negative diluted EPS. The central setup is therefore the contrast between rapid reported revenue growth and the trading, liquidity, and compliance consequences of delisting.
NTRP’s decision not to appeal removes a potential near-term route to preserving its Nasdaq status. The next points to watch are the timing and mechanics of the OTC transition, along with the company’s ability to sustain revenue growth and address its negative earnings profile.
The case — both sides
The strongest bull case is the $3.7M revenue base and 641.0% YoY growth, which could support the company if that growth proves durable after the listing change.
The bear case is stronger: NusaTrip will not appeal the delisting determination, is moving toward OTC trading, and reported diluted EPS of $-1.82, leaving a direct liquidity and earnings overhang.
The house read
Leans bearThe delisting decision moves the risk to the downside for NTRP as the company accepts OTC trading despite $3.7M of revenue and 641.0% YoY growth, with diluted EPS at $-1.82.
Wrong ifThe setup weakens if NusaTrip reverses the delisting process or secures continued Nasdaq trading, while the reported 641.0% YoY revenue growth could also attract enough demand to offset the OTC transition.
Published read · research, not advice